SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Bio Technology General - BTGC
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Michael G. Potter who wrote (1876)7/13/1999 12:35:00 PM
From: Bosco  Read Replies (2) of 2028
 
G'day all - yes, I agree jubilation is a bit premature [no pun intended.] However, if the application can be proven to be of high utility in a more thorough Phase II trial, my guess is that there is a good chance of gaining fast track status. Premies may not be as appealing as dragged diseases like terminal cancers or AIDS etc, but a heart wrenching life experience nonetheless. Of course, if additional Phase II demonstrates high efficacy, BTGC stock will probably move ahead of itself.

best, Bosco
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News